Dexus enters JV to set up healthcare fund
Dexus has entered into a joint venture agreement (JV) with Commercial & General (C&G) to establish a new wholesale unlisted healthcare fund.
Under the terms of the deal, Dexus and C&G would co-invest in the fund and would set up a jointly owned investment manager, with Dexus’ initial co-investment of approximately $80 million.
The responsible entity (RE) of the new Australian Healthcare Property Fund would be wholly owned by Dexus as part of the group’s funds management platform.
Also, the new fund would be seeded with $370 million worth of properties, including the Adelaide Calvary Hospital and GP Plus Healthcare Centre in Adelaide.
Dexus said that healthcare property presented an opportunity for the company to drive long-term returns through leveraging capabilities of its platform across transactions, development, leasing and investment management.
Dexus’ chief executive, Darren Steinberg, said: “We are pleased to partner with C&G and look forward to continuing to build scale in the growing healthcare sector which will benefit from the underlying mega-trends of population growth and an ageing demographic”.
“We see this property asset class as a logical extension to our funds management platform.”
Marketing of the new fund would start in July with a view to launching the fund by the end of 2017, the company said.
AUTHOR
Oksana Patron
Recommended for you
Lazard Asset Management has announced the launch of a new global equity fund, expanding its qualitative offering for Australian investors.
After introducing its first active ETF to the Australian market earlier this year, BlackRock is now preparing to launch its first actively managed, income-focused ETF by the end of November.
Milford Australia has welcomed two new funds to market, driven by advisers’ need for more liquid, transparent credit solutions that meet their strong appetite for fixed income solutions.
Perennial Partners has entered into a binding agreement to take a 50 per cent stake in Balmoral Investors and appoint it as the manager of Perennial's microcap strategy.
